FDA Inspection
Emery PharmaEmery Pharma – FDA Inspection, Jul 9, 2025
Record Details
This FDA Inspection record concerns Emery Pharma, with an inspection on July 9, 2025, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · 0744a129-4748-4aa2-ae95-29acab5e28eb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1275327
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.165(c)Sampling and testing plans not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Emery Pharma
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 16, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Emery Pharma
- FDA Inspection 1073519 - 2018-11-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.